The independent source for health policy research, polling, and news.
15,761-15,780 of 112,929 results
New York City Mayor Bill de Blasio says there will be no restrictions on restaurants, retail or any other businesses. Across the U.S., other reopenings are planned, but experts caution more vaccinations must happen. And the CDC's mask guidance may be causing confusion.
The World Health Organization previously reported a link between covid in humans and disease in bats. In other news, obesity and severe diabetes are linked to worse covid outcomes, while high case numbers in the Pacific Northwest and elsewhere cause concern.
A bill that seems destined for Gov. Greg Gianforte's desk would not allow any business, including all health care facilities, to require any type of vaccination. To protect patients, health care groups say they would require every person to wear a mask, and no visitors would be allowed. That would include expectant fathers or people visiting their elderly parents at a nursing home.
Sources tell The Wall Street Journal that the company missed its April target for filing for emergency use authorization and is now expecting to apply in mid-May. The company also revealed in financial reports that it has so far lost money with its covid vaccine.
Many people are shaking off their fears of the Johnson & Johnson shot. Meanwhile, some health officials say that full FDA approval of all covid vaccines could help fight hesitation.
Senate Finance Committee Chair Ron Wyden has spent years trying to push through pharmaceutical drug pricing reforms. But in the current climate, he is ditching previous efforts and has taken on the task of trying to craft a new package.
Citing a disproportionate effect on health of African Americans, the FDA will ban manufacturing, import and sales--but not personal possession. Tobacco companies are reportedly "infuriated."
The Pentagon and other federal agencies are investigating two possible incidents in the D.C. area. The events raise concerns about a link to suspected uses of invisible weapons on U.S. diplomats abroad that have led to illness referred to as "Havana syndrome."
At this classic 100-day benchmark, news outlets evaluate the accomplishments of President Joe Biden's early days in office and look ahead to the next phase of his tenure -- especially on family leave and abortion.
Though the White House has said it prefers to push such a Medicare measure separately from its proposed $1.8 trillion economic package, Democrats in Congress will pursue pairing the two.
Today's early morning highlights from the major news organizations.
Editorial pages tackle these public health issues.
Opinion writers delve into covid and vaccine issues.
A sampling of this morning's commentary on President Joe Biden's speech to Congress.
In other news around the globe, BioNTech considers producing vaccines in Africa to boost supplies; Brazil's Sputnik V ban gets scientific approval; Germany will surveil covid deniers as threats to the state; and Peru has an unwelcome TB comeback.
$100 million worth of U.S. aid for hospitals and health care workers will start arriving today as nearly 400,000 new covid cases are reported in India. Bloomberg reports that global giant companies like Amazon are also stepping in to help.
Among other reports from across the states, Michigan considers legal limits for marijuana blood levels in drivers, Texas moves to expand medical marijuana use and Missouri's Senate votes down funding for Medicaid expansion.
An analysis shows diversity efforts in US medical schools have been failing, with figures worsening over 40 years. In other news, Michigan tries "recharge rooms" to help tired medical staff and new CMS rules boost star ratings for acute-care hospitals.
Exposure to two or more from a list of issues including alcohol use, marijuana use and gestational diabetes are to blame. Cruise ship restarts, HPV vaccines and air pollution are also in the news.
Stat reports on how much less money citizens in places like Australia and France pay for brand-name blood clot drugs or cancer treatment pills. Separately, the FDA threatens to fine drug maker Acceleron Pharma over clinical trial transparency.
© 2026 KFF